Ticker
LGVNCompany Name
LONGEVERON INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -18.54M | -894.31% | $ 2.07M |
3/31/2025 | $ -16.92M | -760.63% | $ 2.23M |
12/31/2024 | $ -15.97M | -667.77% | $ 2.39M |
9/30/2024 | $ -17.92M | -967.49% | $ 1.85M |
6/30/2024 | $ -18.61M | -1513.83% | $ 1.23M |
3/31/2024 | $ -20.82M | -2129.24% | $ 978K |
12/31/2023 | $ -21.41M | -3020.17% | $ 709K |
9/30/2023 | $ -19.84M | -2587.09% | $ 767K |
6/30/2023 | $ -19.98M | -2265.42% | $ 882K |
3/31/2023 | $ -19.97M | -1765.96% | $ 1.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for LONGEVERON INC is calculated as follows: EBIT [ $ -2.96M ] / Revenues [ $ 5.64M ]
(=) EBIT % [ -52.48% ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2019
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |